iBIO NEWS
Your source for the news and events happening in our communityiBIO NEWS
COMMUNITY NEWS
ALL NEWS
Syntax Bio Emerges with Innovative Cell Therapy Platform
Syntax Bio has launched with $15 million in funding from notable investors, including Astellas...
Promising Signs for MAIA’s Novel Lung Cancer Treatment
MAIA Biotechnology (NYSE American: MAIA) has announced encouraging interim survival data for its...
iBIO’s EPIC Pilot Project Wraps Up, Showcasing Educators and Employers Driving Real-World Learning
We are thrilled to announce the successful completion of the EPIC (Employer Provided Innovation...
Committee Shines Light on PBM Practices and Specialty Pharmacy Concerns
In a recent hearing, the Health Care Availability & Accessibility Committee delved into the...
Chicago-based 32 Biosciences Emerges from Stealth Mode
In a significant development for the healthcare industry, Chicago-based 32 Biosciences has...
iBIO Joins Urgent Call for Rare Pediatric Disease Program Reauthorization
iBIO has joined forces with fellow members of the Council of State Bioscience Associations (CSBA)...
Laughing in the Face of Pain: Amy and Pat Tomasulo’s Fight Against Trigeminal Neuralgia
Amy Tomasulo battles trigeminal neuralgia, a rare neurological disorder that inflicts some of the...
Chicago Becomes U.S. Base for Global Rare Disease Company
Immedica Pharma AB, a Stockholm-based pharmaceutical company specializing in rare and severe...
Illinois Universities Shine in PitchBook’s 2024 Startup Founder Rankings
PitchBook, a leading financial data and software company, has released its highly anticipated 2024...
Investing in Tomorrow: How 2024 Is Reshaping Biopharma’s Trajectory
The biopharma sector's performance in Q2 2024 presents a compelling narrative of resilience and...